Inovio Pharmaceuticals was awarded $ 9 million from CEPI to develop a vaccine against the severe acute respiratory syndrome coronavirus 2 .
Inovio Pharmaceuticals , a San Diego based company which was awarded $ 9m from CEPI , has a candidate vaccine INO-4800 developed and has already started preclinical testing .
Severe acute respiratory syndrome coronavirus 2